ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL3130 |
|
677338-12-4 |
PIK-90 98+% |
C18H17N5O3 | |
CL1320A |
|
934389-88-5 |
LY294002 hydrochloride (LY294002 HCl) 98+% |
C19H17NO3·HCl | |
CL2968 |
|
334969-03-8 |
Recilisib | ON 01210 | EX-RAD 98+% |
C16H13ClO4S | |
CL2966 |
|
1881233-39-1 |
PI4KIIIbeta-IN-10 98+% |
C22H25N3O5S2 | |
CL2964 |
|
1887095-82-0 |
RapaLink-1 98+% |
C91H138N12O24 | |
CL2963 |
|
1226801-23-5 |
LY2780301 98+% |
C25H27F4N7O | |
CL2885 |
|
677297-51-7 |
TG100-115 98+% |
C18H14N6O2 | |
CL2088C |
|
2070009-64-0 |
Afuresertib-F HCl | GSK2110183-analog 1 HCl | 98+% |
C18H17Cl3F2N4OS | |
CL2088B |
|
1047634-63-8 |
Afuresertib-F free base | Afuresertib-F free base | GSK-2110183-analog 1 98+% |
C18H16Cl2F2N4OS | |
CL1332A |
|
1584128-91-5 |
Alpelisib hydrochloride 98+% |
C19H23ClF3N5O2S | |
CL2088A |
|
1047645-82-8 |
Afuresertib HCl | Afuresertib hydrochloride | GSK2110183 hydrochloride | LAE002 hydrochloride 98+% |
C18H17Cl2FN4OS | |
CL2744 |
|
1197160-78-3 |
Gedatolisib | PKI-587 | PF-05212384 98+% |
C32H41N9O4 | |
CL2601 |
|
915019-65-7 |
NVP-BEZ235 (Synonyms: Dactolisib; BEZ235) 98+% |
C30H23N5O | |
CL2556 |
|
1313439-71-2 |
ALM301 98+% |
C25H25N3O3 | |
CL2496 |
|
1223001-51-1 |
Torin 2 98+% |
C24H15F3N4O | |
CL2198 |
|
1144068-46-1 |
WYE-132(WYE-125132) 98+% |
C27H33N7O4 | |
CL2143 |
|
938440-64-3 |
KU-0063794 98+% |
C25H31N5O4 | |
CL1233 |
|
2060571-02-8 |
Inavolisib | GDC-0077 | RG6114 | RO-7113755 98+% |
C18H19F2N5O4 | |
CL1332 |
|
1217486-61-7 |
Alpelisib | BYL-719 98+% |
C19H22F3N5O2S | |
CL1337 |
|
1086062-66-9 |
Omipalisib | GSK2126458 | GSK458 98+% |
C25H17F2N5O3S | |